by University of Auckland Credit: CC0 Public Domain Old medicines, combined in new ways, are showing promise for treating bowel cancer, a group of University of Auckland researchers has found. “While there have been advances in treatments for this disease in recent years, the development of new medicines is expensive and time-consuming,” lead researcher Professor Peter Shepherd...
Finding new ways to treat the novel coronavirus and its ever-changing variants has been a challenge, especially when traditional drug development and discovery process can take years. “The COVID-19 virus is a challenge because it continues to evolve,” says Bin Chen, an associate professor in the College of Human Medicine at Michigan State University. “By...
By PROF. KARIM FIZAZI, MEDICAL ONCOLOGIST, INSTITUTE GUSTAVE ROUSSY AND PROFESSOR IN ONCOLOGY, UNIVERSITY OF PARIS-SACLAY, VILLEJUIF, FRANCE CREDIT: ESMO Lugano, Switzerland, 19 September 2021 – A novel combination of well-known drugs prolongs survival in patients with hormone/castration-sensitive prostate cancer, according to late breaking research presented at the ESMO Congress 2021. (1,2) The PEACE-1 and STAMPEDE studies found that the addition of abiraterone acetate plus prednisolone (AAP) to standard therapy lengthened survival compared...
